In the last trading session, 7,676,527 shares of the Boston Scientific Corporation (NYSE:BSX) were traded, and its beta was 0.84. Most recently the company’s share price was $38.95, and it changed around -$0.09 or 0% from the last close, which brings the market valuation of the company to $55.16 Billion. BSX currently trades at a discount to its 52-week high of $42.37, offering almost -8.78% off that amount. The share price’s 52-week low was $32.99, which indicates that the current value has risen by an impressive 15.3% since then. We note from Boston Scientific Corporation’s average daily trading volume that its 10-day average is 5.85 Million shares, with the 3-month average coming to 9.67 Million.
Boston Scientific Corporation stock received a consensus recommendation rating of Buy, based on a mean score of 1.7. If we narrow it down even further, the data shows that none out of 27 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 5 recommended BSX as a Hold, whereas 21 deemed it a Buy, and no one rated it as Underweight. Boston Scientific Corporation is expected to report earnings per share of $0.3 for the current quarter.
Boston Scientific Corporation (NYSE:BSX): Trading Information
The consensus price target as assigned by Wall Street analysts is $43.36, which translates to bears needing to increase their stock price by 11.32% from its current value. Analyst projections state that BSX is forecast to be at a low of $39 and a high of $50. In order for the stock price to hit the forecast high, the stock would need to surge +28.37% from its current level, while the stock would need to crash 0.13% from its current level to reach the projected low.
Boston Scientific Corporation (BSX) projections and forecasts
Boston Scientific Corporation share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +1.22 percent over the past six months and at a 59.38% annual growth rate that is well above the industry average of 14.8%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +7.1% in revenue this quarter, and will report an increase of 337.5% in the next quarter. The year-over-year growth rate is expected to be 15%, up from the previous year.
Consensus estimates provided by 23 financial analysts predict the company will bring in an average of $2.62 Billion in revenue for the current quarter. 23 analysts expect Boston Scientific Corporation to make $2.76 Billion in revenue for the quarter ending June 01, 2021. The company’s sales for the same quarters a year ago were $2.54 Billion and $2Billion respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 3%. Forecasts for the next quarter put sales growth at 37.9%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 14.6%. Boston Scientific Corporation earnings are expected to decrease by -119.1% in 2021, but the outlook is positive 6.55% per year for the next five years.
Boston Scientific Corporation (NYSE:BSX)’s Biggest Investors
Vanguard Group, Inc. (The), with 7.82% or 112.01 Million shares worth $4.28 Billion as of Sep 29, 2020, holds the second largest percentage of outstanding shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Vanguard Total Stock Market Index Fund and Vanguard Specialized-Health Care Fund were the top two Mutual Funds as of Sep 29, 2020. The former held 40109537 shares worth $1.53 Billion, making up 2.8% of all outstanding shares. On the other hand, Vanguard Specialized-Health Care Fund held roughly 37.32 Million shares worth around $1.28 Billion, which represents about 2.61% of the total shares outstanding.